Quipt Home Medical Corp. (QIPT.TO) Research

Quipt Home Medical Corp. specializes in delivering a broad array of essential medical devices and supplies directly to patients' homes across the United States, encompassing both respiratory and durable medical equipment. The company focuses on supporting individuals grappling with chronic illnesses, particularly those affected by cardiac and pulmonary conditions, sleep apnea, limited mobility, and other persistent health challenges. Their extensive product catalog includes diverse therapeutic and mobility aids, such as oxygen concentrators, ventilators, CPAP and BiPAP devices (along with masks and accessories), nebulizers, humidifiers, hospital beds, patient lifts, wheelchairs, walkers, canes, bariatric solutions, bathroom safety products, and wound care items. Beyond equipment, they provide comprehensive services like home-based treatments for sleep apnea and chronic obstructive pulmonary disease (COPD), logistical support for healthcare delivery, and oxygen therapy, with convenient home and hospital delivery options. Established in 1993 as Protech Home Medical Corp., the company rebranded as Quipt Home Medical Corp. in May 2021 and maintains its corporate headquarters in Wilder, Kentucky.

Market snapshot

Symbol
QIPT.TO
Price
$4.98
Day change
+0.40%
Market cap
$157.1M
P/E ratio
-14.44x
52-week range
1.9-5
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Cannabix Technologies Inc. (BLO.CN)
  • Cardiol Therapeutics Inc. (CRDL.TO)
  • Grown Rogue International Inc. (GRIN.CN)
  • Helix BioPharma Corp. (HBP.TO)
  • HLS Therapeutics Inc. (HLS.TO)
  • Cannara Biotech Inc. (LOVE.V)
  • Medicenna Therapeutics Corp. (MDNA.TO)
  • Satellos Bioscience Inc. (MSCL.TO)

Open Quipt Home Medical Corp. (QIPT.TO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.